GRAPHITE BIO INC (GRPH) Stock Income Statement
NASDAQ:GRPH - Nasdaq - US38870X1046 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 73.11M | 105.64M | 60.44M | 13.50M | 30.00K | |||
| Research and Development | 32.14M | 72.79M | 37.93M | 9.12M | 0.00 | |||
| Selling, General, and Administrative Expenses | 40.97M | 32.85M | 22.51M | 4.38M | 30.00K | |||
| Operating Income | -73.11M | -105.64M | -60.44M | -13.50M | -30.00K | |||
| Interest Income/Expense | 10.95M | N/A | 0.00 | -40.00K | -80.00K | |||
| Other Income/Expense | -338.00K | 4.59M | -10.32M | -54.83M | 0.00 | |||
| Non Recurring Items | -62.08M | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -124.65M | -101.05M | -70.76M | -68.37M | -110.00K | |||
| Net Income | -124.65M | -101.05M | -70.76M | -68.37M | -110.00K | |||
| EBITDA | -70.70M | -103.29M | -59.71M | -13.38M | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.19 | -1.84 | -2.45 | -1.18 | 0.00 | |||
| Non GAAP EPS | -2.19 | -1.85 | N/A | N/A | N/A | |||
| Statistics | ||||||||
All data in USD